China Universal Asset Management Company’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-104
| Closed | -$3.83K | – | 434 |
|
|
2023
Q3 | $3.83K | Buy |
104
+53
| +104% | +$1.95K | ﹤0.01% | 405 |
|
|
2023
Q2 | $2.07K | Sell |
51
-1
| -2% | -$41 | ﹤0.01% | 424 |
|
|
2023
Q1 | $3.77K | Buy |
52
+13
| +33% | +$943 | ﹤0.01% | 394 |
|
|
2022
Q4 | $3.16K | Buy |
39
+4
| +11% | +$324 | ﹤0.01% | 340 |
|
|
2022
Q3 | $3K | Buy |
+35
| New | +$3K | ﹤0.01% | 319 |
|